Plos iconPlosSep 8, 2026 ~6 min source read

7SK RNA links focused oncogene activation to broad transcriptional shutdown to drive therapy resistance

Single-cell multi-omics and functional assays show conserved dual roles for the non-coding RNA 7SK: activating a JUN-driven proliferation program locally while suppressing global transcriptional entropy to stabilize an immunosuppressive microenvironment and promote immune escape.

Non-coding RNA 7SK drives tumor resistance by coupling local oncogenic activation with global transcriptional repression

Share this story

Send the public story page.

Useful takeaways from this story.

7SK simultaneously promotes a local oncogenic program (JUN network) and enforces global transcriptional repression, a dual mechanism that supports tumor proliferation and immune evasion.

This “local activation—global suppression” pattern was identified in chemotherapy-resistant colorectal cancer using single-cell multi-omics and validated across multiple cancer cohorts.

Reduced global transcriptional entropy under 7SK correlates with a colder, immunosuppressive tumor microenvironment that favors resistant clones.

# What the paper found

# The two-axis mechanism

  • Local activation: 7SK selectively activates the JUN transcriptional network. That activation fuels proliferation in resistant cancer cells, effectively pressing a growth accelerator on a focused oncogenic module.
  • Global suppression: at the same time, 7SK lowers global transcriptional entropy—meaning overall gene expression becomes more ordered and broadly dampened. That global repression appears to stabilize an immunosuppressive tumor microenvironment and reduce immune signaling, helping tumors escape immune attack.

# How they reached this conclusion The authors integrated single-cell RNA-seq and spatial transcriptomics with functional experiments on colorectal cancer (CRC) samples. They analyzed transcriptional states at single-cell resolution to link 7SK expression with both JUN-network activity and measures of global transcriptional disorder. Functional assays supported the causal role of 7SK in driving these transcriptional effects. The study also validated findings across multiple independent datasets to test conservation beyond CRC.

# Why reduced transcriptional entropy matters here Lower transcriptomic entropy means less cell-to-cell variation in gene expression and a more uniformly repressed global program. In this work, that lower entropy correlated with a microenvironment exhibiting fewer immune-activating signals—a "cold" environment that facilitates immune escape and supports the survival and expansion of resistant clones under therapeutic pressure.

# Evidence for conservation across cancers The authors report that the local activation–global suppression paradigm driven by 7SK is observable across several cancer types beyond colorectal cancer. That cross-cancer conservation suggests 7SK's role is not a context-specific quirk but a repeatable transcriptional strategy tumors can use to survive therapy.

# Data availability and resources All single-cell RNA-seq and spatial transcriptomics data generated in the primary cohort were deposited in CNGBdb (accession CNP0004138). The authors used additional public cohorts for validation, including GEO datasets (GSE236581, GSE200997), the 3CA database, and TCGA Pan-Cancer data via UCSC Xena.

# Practical implications

# Bottom line 7SK acts as a dynamic transcriptional coordinator: it enables tumors to keep a selected proliferation program active while globally quieting transcriptional noise and immune signals. That coordinated behavior helps tumor cells resist chemotherapy and evade immune attack, and it appears in multiple cancer types, making 7SK a candidate target for efforts to overcome resistance.

More context around this story.

Loading more related stories...

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app